Frontlight ResearchEarly access
Kidney cancer trials in United States
210 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleBrodalumab in the Treatment of Immune-Related Adverse Events
- Where
- New York
- Age
- 18 years and over
- People
- 11
- Run by
- Brian Henick, MD
See details and how to joinNCT06673329 - Phase 2Not yet taking people in United StatesZanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
- Where
- Duarte
- Age
- 18 years and over
- People
- 34
- Run by
- City of Hope Medical Center
See details and how to joinNCT07578025 - Phase 2Taking peoplePhase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
- Where
- Birmingham, Chicago, Cleveland, St Louis, Weston
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Advenchen Pharmaceuticals, LLC.
See details and how to joinNCT05363280 · EU 2023-509067-24-01 - No phaseTaking peoplePilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
- Where
- Nashville
- Age
- 18 years and over
- People
- 25
- Run by
- Jessica Mezzanotte Sharpe
See details and how to joinNCT07555210 - No phaseTaking peopleComparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Where
- Birmingham, Duarte, Fresno, Fruitdale, Fullerton, Honolulu, Las Vegas, Los Angeles, Mather, Mobile, Monterey, Palo Alto, Salt Lake City, San Francisco
- Age
- 18 years and over
- People
- 2,996
- Run by
- Stanford University
See details and how to joinNCT05297734 - Phase 1Taking peoplePhase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07072234 - Phase 1/2Taking peopleA First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Where
- Chapel Hill, Chicago, Grand Rapids, Houston, Lake Success, Los Angeles, North Haven, Pittsburgh, San Antonio, San Francisco
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06413680 · EU 2025-523399-22-00 - Phase 2Taking peopleTreatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
- Where
- Memphis
- People
- 260
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04968990 - Phase 2Taking peoplePatient Preference for Subcutaneous vs. Intravenous Immune Therapy
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 880
- Run by
- Diwakar Davar
See details and how to joinNCT07223424 - Early phase 1Taking peoplePencil Beam Scanning in Patients With Renal Tumors
- Where
- Philadelphia
- Age
- 0 years to 30 years
- People
- 28
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT03810651 - Phase 1Taking peopleVorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- Where
- Valhalla
- Age
- 1 year to 30 years
- People
- 30
- Run by
- New York Medical College
See details and how to joinNCT04308330 - No phaseTaking peopleCryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04693377 - Phase 2Taking peopleNeoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
- Where
- Aurora, Highlands Ranch, Lone Tree
- Age
- 18 years and over
- People
- 17
- Run by
- University of Colorado, Denver
See details and how to joinNCT05969496 - Phase 1/2Taking peopleA Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Where
- Aurora, Houston, Lake Mary, Lebanon, Providence
- Age
- 18 years and over
- People
- 126
- Run by
- 7 Hills Pharma, LLC
See details and how to joinNCT06362369 - No phaseTaking peopleKidney Cancer DNA Registry
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 750
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT02087852 - Phase 1Taking peopleA Study of VET3-TGI in Patients With Solid Tumors
- Where
- Dallas, Houston, Indianapolis, Los Angeles, Miami, Orange, Pittsburgh
- Age
- 18 years and over
- People
- 60
- Run by
- KaliVir Immunotherapeutics
See details and how to joinNCT06444815 - Phase 2Taking peopleStereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 20
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06376669 - Phase 1Taking peopleThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Where
- Austin, TX 78758, Boston, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Zumutor Biologics Inc.
See details and how to joinNCT06451497 - Phase 1/2Taking peopleStudy to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC
- Where
- Buffalo
- Age
- 18 years and over
- People
- 28
- Run by
- State University of New York at Buffalo
See details and how to joinNCT06222593 - Phase 2Taking peopleStudy of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
- Where
- Baltimore
- Age
- 18 years to 120 years
- People
- 20
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT03786796 - Phase 2Taking peoplePre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
- Where
- Boston
- Age
- 18 years and over
- People
- 32
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07397611 - Phase 1/2Taking people64Cu-GRIP B in Patients With Advanced Malignancies
- Where
- San Francisco
- Age
- 18 years and over
- People
- 91
- Run by
- Rahul Aggarwal
See details and how to joinNCT05888532 - No phaseTaking peopleImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Where
- Jacksonville, Phoenix, Rochester
- Age
- 18 years and over
- People
- 324
- Run by
- Mayo Clinic
See details and how to joinNCT06349642 - Phase 2Taking peopleComprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
- Where
- Houston
- Age
- 18 years and over
- People
- 148
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT07050771 - No phaseTaking peopleThe Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry
- Where
- Baltimore
- Age
- 18 years to 100 years
- People
- 600
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT02346435